Aprepitant 40 MG capsule UD 5S
Ended Awarded
- Contract number
- SPE2DB25FYBZ0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,108
Award facts
- Contract value 100% obligated
- $2,107.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Aprepitant 40 mg capsules in unit dose packages of five, with a ceiling value of $2,107.60 and a firm fixed price structure. This competitively awarded, non-set-aside contract is scheduled for completion by June 12, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. Aprepitant is a chemotherapy-induced nausea and vomiting (CINV) medication commonly used in military and veteran healthcare settings, reflecting the Defense Logistics Agency's pharmaceutical procurement priorities for the Military Health System.
This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime vendor contract establishes a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to provide a broad range of medications, vaccines, and medical supplies to support military healthcare operations globally. As a major pharmaceutical distributor, AmerisourceBergen maintains a critical role in the Defense Logistics Agency's supply chain, consistently delivering both specialty and generic pharmaceutical products to support Department of Defense and other federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FYBZ0?
SPE2DB25FYBZ0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 11, 2025.
How much is contract SPE2DB25FYBZ0 worth?
The government has obligated $2,108 on SPE2DB25FYBZ0.
Is contract SPE2DB25FYBZ0 an order under another contract?
Yes. SPE2DB25FYBZ0 is a delivery order under SPE2DB24D1104, an indefinite delivery contract.
Was contract SPE2DB25FYBZ0 competed?
The extent of competition for SPE2DB25FYBZ0 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award